4-Bromo-1-(2-methanesulfonylethyl)-1h-pyrazole, 95%, 5g

Laquinimod>95.0%(HPLC)(T)100mg

Centrifuge tubes conical, without rim, 50 ml, Non-sterile, 300 Piece(s)

3-(4-Chlorophenyl)-4H-1,2,4-triazole, 98%, 5g

2-Methyl-2-adamantanol, min. 98%, for synthesis, 5 g, glass packaging

1-Methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxylic acid, 95.0%, 2g

4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole, 95.0%, 10g

Mal-PEG4-OH, 5g

4-CHLORO-5-FLUORO-7-AZA-2-OXINDOLE, 95.0%, 10g

2,4,6-Tribromo-3-nitroaniline, 96.0%, 25g

(S)-1,1,1,4,4,4-Hexafluoro-2-butylamine, 94.0%, 250mg

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine, 25mg

Benzyl aziridine-1-carboxylate, 95.0%, 100mg